Genogroup II Noroviruses Efficiently Bind to Heparan Sulfate Proteoglycan Associated with the Cellular Membrane

Journal of Virology

Volumn 78, Issue 8, 2004, Pages 3817-3826

  Tamura, Masaru ^a,b,c   Natori, Katsuro ^a   Kobayashi, Masahiko ^b   Miyamura, Tatsuo ^a   Takeda, Naokazu ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; BLOOD GROUP H ANTIGEN; BOVINE SERUM ALBUMIN; CECROPIN; CHONDROITIN 6 SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN POLYSULFATE; HEPARAN SULFATE; HEPARIN; HEPARIN LYASE; HYALURONIC ACID; MAGAININ 1; POLYLYSINE; PROTAMINE SULFATE; PROTEOHEPARAN SULFATE; SURAMIN; UNCLASSIFIED DRUG; UREA;

ACUTE GASTROENTERITIS; ARTICLE; BINDING SITE; CALICIVIRUS; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; MAMMAL; NONHUMAN; NOROVIRUS GENOGROUP II; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; REDUCTION; STATISTICAL SIGNIFICANCE; SULFATION; VIRUS CELL INTERACTION; VIRUS PARTICLE;

ABO BLOOD-GROUP SYSTEM; ANIMALS; BINDING SITES; CACO-2 CELLS; CELL DIFFERENTIATION; CELL LINE; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; CHO CELLS; CRICETINAE; HELA CELLS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; NOROVIRUS; RECOMBINATION, GENETIC; VERO CELLS;

EID: 1842589456     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.8.3817-3826.2004     Document Type: Article

References (85)

1. Adler, J. L., and R. Zickl. 1969. Winter vomiting disease. J. Infect. Dis. 119:668-673.
2. Amano, J., and M. Oshima. 1999. Expression of the H type 1 blood group antigen during enterocytic differentiation of Caco-2 cells. J. Biol. Chem. 274:21209-21216.
3. Anderson, M. J., F. G. Klier, and K. E. Tanguay. 1984. Acetylcholine receptor aggregation parallels the deposition of a basal lamina proteoglycan during development of the neuromuscular junction. J. Cell Biol. 99:1769-1784.
4. Ando, T., J. S. Noel, and R. L. Fankhauser. 2000. Genetic classification of "Norwalk-like viruses." J. Infect. Dis. 181:S336-S348.
5. Baeuerle, P. A., and W. B. Huttner. 1986. Chlorate - a potent inhibitor of protein sulfation in intact cells. Biochem. Biophys. Res. Commun. 141:870-877.
6. Ball, J. M., M. E. Hardy, R. L. Atmar, M. E. Conner, and M. K. Estes. 1998. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J. Virol. 72:1345-1353.
7. Basavappa, R., A. Gomez-Yafal, and J. M. Hogle. 1998. The poliovirus empty capsid specifically recognizes the poliovirus receptor and undergoes some, but not all, of the transitions associated with cell entry. J. Virol. 72:7551-7556.
8. Bilozur, M. E., and C. Biswas. 1990. Identification and characterization of heparan sulfate-binding proteins from human lung carcinoma cells. J. Biol. Chem. 265:19697-19703.
9. Bornens, M. 1973. Action of heparin on nuclei: solubilization of chromatin enabling the isolation of nuclear membranes. Nature 244:28-30.
10. Cassaro, C. M. F., and C. P. Dietrich. 1977. Distribution of sulfated mucopolysaccharides in invertebrates. J. Biol. Chem. 252:2254-2261.
11. Chen, Y., T. Maguire, R. E. Hileman, J. R. Fromm, J. D. Esko, R. J. Linhardt, and R. M. Marks. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3:866-871.
12. Cole, G. J., A. Loewy, and L. Glaser. 1986. Neuronal cell-cell adhesion depends on interactions of N-CAM with heparin-like molecules. Nature 320:445-447.
13. Crowell, R. L., and L. Philipson. 1971. Specific alterations of coxsackievirus B3 eluted from HeLa cells. J. Virol. 8:509-515.
14. Dietrich, C. P., H. B. Nader, and A. H. Straus. 1983. Structural differences of heparan sulfates according to the tissue and species of origin. Biochem. Biophys. Res. Commun. 111:865-871.
15. Esko, J. D., K. S. Rostand, and J. L. Weinke. 1988. Tumor formation dependent on proteoglycan biosynthesis. Science 241:1092-1096.
16. Fransson, L. A., I. Sjoberg, and B. Havsmark. 1980. Structural studies on heparan sulphates. Characterization of oligosaccharides; obtained by periodate oxidation and alkaline elimination. Eur. J. Biochem. 106:59-69.
17. Frenster, J. H. 1965. Nuclear polyanions as de-repressors of synthesis of ribonucleic acid. Nature 206:680-683.
18. Glass, P. J., L. J. White, J. M. Ball, I. Leparc-Goffart, M. E. Hardy, and M. K. Estes. 2000. Norwalk virus open reading frame 3 encodes a minor structural protein. J. Virol. 74:6581-6591.
19. Gray, J. J., X. Jiang, P. Morgan-Capner, U. Desselberger, and M. K. Estes. 1993. Prevalence of antibodies to Norwalk virus in England: detection by enzyme-linked immunosorbent assay using baculovirus-expressed Norwalk virus capsid antigen. J. Clin. Microbiol. 31:1022-1025.
20. Green, K. Y. 2000. Summary of the first international workshop on human caliciviruses. J. Infect. Dis. 181:S252-S253.
21. Green, K. Y., R. M. Chanock, and A. Z. Kapikian. 2001. Human caliciviruses, p. 841-874. In D. M. Knipe and P. M. Howley (ed.), Fields virology, vol. 1. Lippincott Williams & Wilkins, Philadelphia, Pa.
22. Green, K. Y., J. F. Lew, X. Jiang, A. Z. Kapikian, and M. K. Estes. 1993. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J. Clin. Microbiol. 31:2185-2191.
23. Greenberg, H. B., J. Valdesuso, R. H. Yolken, E. Gangarosa, W. Gary, R. G. Wyatt, T. Konno, H. Suzuki, R. M. Chanock, and A. Z. Kapikian. 1979. Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J. Infect. Dis. 139:564-568.
24. Griffin, M. R., J. J. Surowiec, D. I. McCloskey, B. Capuano, B. Pierzynski, M. Quinn, R. Wojnarski, W. E. Parkin, H. Greenberg, and G. W. Gary. 1982. Foodborne Norwalk virus. Am. J. Epidemiol. 115:178-184.
25. Grohmann, G. S., A. M. Murphy, P. J. Christopher, E. Auty, and H. B. Greenberg. 1981. Norwalk virus gastroenteritis in volunteers consuming depurated oysters. Aust. J. Exp. Biol. Med. Sci. 59:219-228.
26. Guerrero, R. A., J. M. Ball, S. S. Krater, S. E. Pacheco, J. D. Clements, and M. K. Estes. 2001. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J. Virol. 75:9713-9722.
27. Hardingham, T. E., and A. J. Fosang. 1992. Proteoglycans: many forms and many functions. FASEB J. 6:861-870.
28. Harrington, P. R., L. Lindesmith, B. Yount, C. L. Moe, and R. S. Baric. 2002. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J. Virol. 76:12335-12343.
29. Hedman, K., M. Kurkinen, K. Alitalo, A. Vaheri, S. Johansson, and M. Hook. 1979. Isolation of the pericellular matrix of human fibroblast cultures. J. Cell Biol. 81:83-91.
30. Hink, W. F. 1970. Establish insect cell line from the cabbage looper, Trichoplusia ni. Nature 226:466-467.
31. Hutson, A. M., R. L. Atmar, D. Y. Graham, and M. K. Estes. 2002. Norwalk virus infection and disease is associated with ABO histo-blood group type. J. Infect. Dis. 185:1335-1337.
32. Hutson, A. M., R. L. Atmar, D. M. Marcus, and M. K. Estes. 2003. Norwalk virus-like particle hemagglutination by binding to H histo-blood group antigens. J. Virol. 77:405-415.
33. Jiang, X., D. Y. Graham, K. Wang, and M. K. Estes. 1990. Norwalk virus genome cloning and characterization. Science 250:1580-1583.
34. Jiang, X., M. Wang, D. Y. Graham, and M. K. Estes. 1992. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66:6527-6532.
35. Joklik, W. K., and J. E. Darnell, Jr. 1961. The adsorption and early fate of purified poliovirus in HeLa cells. Virology 13:439-447.
36. Kanwar, Y. S., and M. G. Farquhar. 1979. Presence of heparan sulfate in the glomerular basement membrane. Proc. Natl. Acad. Sci. USA 76:1303-1307.
37. Kapikian, A. Z., R. G. Wyatt, R. Dolin, T. S. Thornhill, A. R. Kalica, and R. M. Chanock. 1972. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J. Virol. 10:1075-1081.
38. Kaplan, J. E., G. W. Gary, R. C. Baron, N. Singh, L. B. Schonberger, R. Feldman, and H. B. Greenberg. 1982. Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann. Intern. Med. 96:756-761.
39. Kaplan, J. E., R. A. Goodman, L. B. Schonberger, E. C. Lippy, and G. W. Gary. 1982. Gastroenteritis due to Norwalk virus: an outbreak associated with a municipal water system. J. Infect. Dis. 146:190-197.
40. Katayama, K., H. Shirato-Horikoshi, S. Kojima, T. Kageyama, T. Oka, F. Hoshino, S. Fukushi, M. Shinohara, K. Uchida, Y. Suzuki, T. Gojobori, and N. Takeda. 2002. Phylogenetic analysis of the complete genome of 18 Norwalk-like viruses. Virology 299:225-239.
41. Kjellen, L., I. Pettersson, and M. Hook. 1981. Cell-surface heparan sulfate: an intercalated membrane proteoglycan. Proc. Natl. Acad. Sci. USA 78:5371-5375.
42. Kobayashi, S., K. Sakae, Y. Suzuki, H. Ishiko, K. Kamata, K. Suzuki, K. Natori, T. Miyamura, and N. Takeda. 2000. Expression of recombinant capsid proteins of chitta virus, a genogroup II Norwalk virus, and development of an ELISA to detect the viral antigen. Microbiol. Immunol. 44:687-693.
43. Kobayashi, S., K. Sakae, Y. Suzuki, K. Shinozaki, M. Okada, H. Ishiko, K. Kamata, K. Suzuki, K. Natori, T. Miyamura, and N. Takeda. 2000. Molecular cloning, expression, and antigenicity of Seto virus belonging to genogroup I Norwalk-like viruses. J. Clin. Microbiol. 38:3492-3494.
44. Laterra, J., J. E. Silbert, and L. A. Culp. 1983. Cell surface heparan sulfate mediates some adhesive responses to glycosaminoglycan-binding matrices, including fibronectin. J. Cell Biol. 96:112-123.
45. Lew, J. F., A. Z. Kapikian, J. Valdesuso, and K. Y. Green. 1994. Molecular characterization of Hawaii virus and other Norwalk-like viruses: evidence for genetic polymorphism among human caliciviruses. J. Infect. Dis. 170:535-542.
46. Lindesmith, L., C. Moe, S. Marionneau, N. Ruvoen, X. Jiang, L. Lindblad, P. Stewart, J. Le Pendu, and R. Baric. 2003. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9:548-553.
47. Lohse, D. L., and R. J. Linhardt. 1992. Purification and characterization of heparin lyases from Flavobacterium heparinum. J. Biol. Chem. 267:24347-24355.
48. Maccarana, M., Y. Sakura, A. Tawada, K. Yoshida, and U. Lindahl. 1996. Domain structure of heparan sulfates from bovine organs. J. Biol. Chem. 271:17804-17810.
49. Marionneau, S., N. Ruvoen, B. Le Moullac-Vaidye, M. Clement, A. Cailleau-Thomas, G. Ruiz-Palacois, P. Huang, X. Jiang, and J. Le Pendu. 2002. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122:1967-1977.
50. Mason, H. S., J. M. Ball, J. J. Shi, X. Jiang, M. K. Estes, and C. J. Arntzen. 1996. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl. Acad. Sci. USA 93:5335-5340.
51. Medeiros, G. F., A. Mendes, R. A. B. Castro, E. C. Bau, H. B. Nader, and C. P. Dietrich. 2000. Distribution of sulfated glycosaminoglycans in the animal kingdom: widespread occurrence of heparin-like compounds in invertebrates. Biochim. Biophys. Acta 1475:287-294.
52. Meeroff, J. C., D. S. Schreiber, J. S. Trier, and N. R. Blacklow. 1980. Abnormal gastric motor function in viral gastroenteritis. Ann. Intern. Med. 92:370-373.
53. Mitsuya, H., D. J. Looney, S. Kuno, R. Ueno, F. Wong-Staal, and S. Broder. 1988. Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells. Science 240:646-649.
54. Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436.
55. Morse, D. L., J. J. Guzewich, J. P. Hanrahan, R. Stricof, M. Shayegani, R. Deibel, J. C. Grabau, N. A. Nowak, J. E. Herrmann, G. Cukor, and N. R. Blacklow. 1986. Widespread outbreaks of clam- and oyster-associated gastroenteritis. Role of Norwalk virus. N. Engl. J. Med. 314:678-681.
56. Nader, H. B., C. P. Dietrich, V. Buonassisi, and P. Colburn. 1987. Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan. Proc. Natl. Acad. Sci. USA 84:3565-3569.
57. Parrino, T. A., D. S. Schreiber, J. S. Trier, A. Z. Kapikian, and N. R. Blacklow. 1977. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N. Engl. J. Med. 297:86-89.
58. Payne, E., M. R. Bowles, A. Don, J. F. Hancock, and N. A. J. McMillan. 2001. Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation. J. Virol. 75:4150-4157.
59. Prasad, B. V. V., M. E. Hardy, T. Dokland, J. Bella, M. G. Rossmann, and M. K. Estes. 1999. X-ray crystallographic structure of the Norwalk virus capsid. Science 286:287-290.
60. Prasad, B. V. V., R. Rothnagel, X. Jiang, and M. K. Estes. 1994. Three-dimensional structure of baculovirus-expressed Norwalk virus capsids. J. Virol. 68:5117-5125.
61. Roberts, R., J. Gallagher, E. Spooncer, T. D. Allen, F. Bloomfield, and T. M. Dexter. 1988. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 332:376-378.
62. Rostand, K. S., and J. D. Esko. 1997. Microbial adherence to and invasion through proteoglycans. Infect. Immun. 65:1-8.
63. Schreiber, D. S., N. R. Blacklow, and J. S. Trier. 1973. The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N. Engl. J. Med. 288:1318-1323.
64. Schreiber, D. S., N. R. Blacklow, and J. S. Trier. 1974. The small intestinal lesion induced by Hawaii agent acute infectious nonbacterial gastroenteritis. J. Infect. Dis. 129:705-708.
65. Shukla, D., J. Liu, P. Blaiklock, N. W. Shworak, X. Bai, J. D. Esko, G. H. Cohen, R. J. Eisenberg, R. D. Rosenberg, and P. G. Spear. 1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus I entry. Cell 99:13-22.
66. Steiner, H., D. Hultmark, A. Engstrom, H. Bennich, and H. G. Boman. 1981. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292:246-248.
67. Subekti, D. S., P. Tjaniadi, M. Lesmana, J. McArdle, D. Iskandriati, I. N. Budiarsa, P. Walujo, I. H. Suparto, I. Winoto, J. R. Campbell, K. R. Porter, D. Sajuthi, A. A. Ansari, and B. A. Oyofo. 2002. Experimental infection of Macaca nemestrina with a Toronto Norwalk-like virus of epidemic viral gastroenteritis. J. Med. Virol. 66:400-406.
68. Subramanian, G., D. S. McClain, A. Perez, and A. O. Fuller. 1994. Swine testis cells contain functional heparan sulfate but are defective in entry of herpes simplex virus, J. Virol. 68:5667-5676.
69. Summerford, C., and R. J. Samulski. 1998. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1438-1445.
70. Tamura, M., K. Natori, M. Kobayashi, T. Miyamura, and N. Takeda. 2003. Inhibition of attachment of virions of Norwalk virus to mammalian cells by soluble histone molecules. Arch. Virol. 148:1659-1670.
71. Tamura, M., K. Natori, M. Kobayashi, T. Miyamura, and N. Takeda. 2000. Interaction of recombinant Norwalk virus particles with the 105-kilodalton cellular binding protein, a candidate receptor molecule for virus attachment. J. Virol. 74:11589-11597.
72. Toida, T., H. Yoshida, H. Toyoda, I. Koshiishi, T. Imanari, R. E. Hileman, J. R. Fromm, and R. J. Linhardt. 1997. Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. Biochem. J. 322:499-506.
73. Toledo, O. M. S., and C. P. Dietrich. 1977. Tissue specific distribution of sulfated mucopolysaccharides in mammals. Biochim. Biophys. Acta 498:114-122.
74. Tsang, S. K., B. M. McDermott, V. R. Racaniello, and J. M. Hogle. 2001. Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst. J. Virol. 75:4984-4989.
75. Vaheri, A. 1964. Heparin and related polyionic substances as virus inhibitors. Acta Pathol. Microbiol. Scand. 171(Suppl.):S1-S98.
76. Villeponteau, B. 1992. Heparin increases chromatin accessibility by binding the trypsin-sensitive basic residues in histones. Biochem. J. 288:953-958.
77. Vlodavsky, I., J. Folkman, R. Sullivan, R. Fridman, R. Ishai-Michaeli, J. Sasse, and M. Klagsbrun. 1987, Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA 84:2292-2296.
78. Wang, J., X. Jiang, H. P. Madore, J. Gray, U. Desselberger, T. Ando, Y. Seto, I. Oishi, J. F. Lew, K. Y. Green, and M. K. Estes. 1994. Sequence diversity of small, round-structured viruses in the Norwalk virus group. J. Virol. 68:5982-5990.
79. Watson, K., N. J. Gooderham, D. S. Davies, and R. J. Edwards. 1999. Nucleosomes bind to cell surface proteoglycans. J. Biol. Chem. 274:21707-21713.
80. White, L. J., J. M. Ball, M. E. Hardy, T. N. Tanaka, N. Kitamoto, and M. K. Estes. 1996. Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines. J. Virol. 70:6589-6597.
81. WuDunn, D., and P. G. Spear. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-58.
82. Wyatt, R. G., H. B. Greenberg, D. W. Dalgard, W. P. Allen, D. L. Sly, T. S. Thornhill, R. M. Chanock, and A. Z. Kapikian. 1978. Experimental infection of chimpanzees with the Norwalk agent of epidemic viral gastroenteritis. J. Med. Virol. 2:89-96.
83. Yamagata, T., H. Saito, O. Habuchi, and S. Suzuki. 1968. Purification and properties of bacterial chondroitinases and chondrosulfatases. J. Biol. Chem. 243:1523-1535.
84. Yayon, A., M. Klagsbrun, J. D. Esko, P. Leder, and D. M. Ornitz. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848.
85. Zasloff, M. 1987. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA 84:5449-5453.